Human autoantibody to vasoactive intestinal peptide: Increased incidence in muscular exercise
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 43 (13) , 1079-1084
- https://doi.org/10.1016/0024-3205(88)90203-2
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxisFEBS Letters, 1987
- Purification and characterisation of VIP from two species of dogfishPeptides, 1986
- The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon and oxyntomodulin). Specificities and identityPeptides, 1986
- Increase in plasma vasoactive intestinal polypeptide (VIP) in muscular exercise in humansGeneral Pharmacology: The Vascular System, 1986
- Analysis of radioligand binding experimentsJournal of Pharmacological Methods, 1985
- Purification of [125I]-vasoactive intestinal peptide by reverse-phase HPLCPeptides, 1984
- Vasoactive intestinal polypeptide (VIP): Current statusPeptides, 1984
- Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27Nature, 1983
- Immune elimination of aging platelets by autologous monocytes: role of membrane‐specific autoantibodyEuropean Journal of Immunology, 1983
- Structure of the vasoactive intestinal octacosapeptide from chicken intestine. The amino acid sequenceFEBS Letters, 1975